WHAT´S NEW in Psoraisis?
In this section you will be able to identify the new content uploaded regularly .
Duration 14:14
Prof. Melinda Gooderham
Speaker, investigator or advisory board member for AbbVie, Actelion, Amgen, Akros, Arcutis, Arena, Bausch, Boehringer Ingelheim, BMS, Celgene, Coherus, Dermira, Eli Lilly, Galderma, Glenmark, GSK, Janssen, Kyowa Kirin, LEO Pharma, MedImmune, Merck, Novartis, Pfizer, Regeneron, Roche Laboratories, Sanofi Genzyme, Sun Pharmaceuticals, Takeda, UCB and Valeant
For Oman HCPs.
Department of Pharmacovigilance & Drug information.
Directorate General of pharmaceutical affairs and Drug control.
Ministry of Health, Sultanate of Oman
Phone Nos:: 22357687 / 22357686
Fax: 22358489
Email: Pharma-Vigil@moh.gov.om
Website:www.moh.gov.om
This website is intended for Gulf Healthcare Professionals
AbbVie Biopharmaceuticals GmbH.
Suite 2901, U Bora Tower,Business Bay, Dubai, UAE
PO Box:: 118052
OFFICE : +971 4 5506100
FAX: +971 4 5506101
Patient Safety is our Priority, we will remain always by your side. For Reporting Adverse events Please Contact.
PV.MEA@Abbvie.com or Hotline: 00971564135746
JAKa-BH-00004-MC